stage ii chronic lymphocytic leukemia
Showing 1 - 25 of 25
Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia Trial in
Active, not recruiting
- Stage I Chronic Lymphocytic Leukemia
- +3 more
- Cyclophosphamide
- +4 more
-
Scottsdale, Arizona
- +363 more
Dec 30, 2022
Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia Trial in
Active, not recruiting
- Stage I Chronic Lymphocytic Leukemia
- +3 more
- Ibrutinib
- Laboratory Biomarker Analysis
-
Jacksonville, FloridaMayo Clinic in Florida
Mar 24, 2022
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Active, not recruiting
- Accelerated Phase Chronic Myelogenous Leukemia
- +125 more
- tetanus-CMV fusion peptide vaccine
- laboratory biomarker analysis
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 28, 2022
Contiguous Stage II Small Lymphocytic Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Prolymphocytic Leukemia Trial
Active, not recruiting
- Contiguous Stage II Small Lymphocytic Lymphoma
- +11 more
- MOR00208
- +2 more
-
Columbus, OhioThe Ohio State University Comprehensive Cancer Center
Feb 24, 2022
Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Adult Diffuse Large Cell
Active, not recruiting
- Adult Grade III Lymphomatoid Granulomatosis
- +71 more
- lenalidomide
- +8 more
-
Chicago, Illinois
- +5 more
Oct 8, 2021
Refractory Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia Trial in
Completed
- Refractory Chronic Lymphocytic Leukemia
- +4 more
- Dasatinib
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Mar 15, 2021
Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Completed
- Hematopoietic/Lymphoid Cancer
- +135 more
- beclomethasone dipropionate
- +4 more
-
Hackensack, New Jersey
- +1 more
Feb 1, 2021
Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia Trial in
Active, not recruiting
- Stage I Chronic Lymphocytic Leukemia
- +3 more
- alemtuzumab
- +2 more
-
Chicago, Illinois
- +1 more
Dec 29, 2020
B-cell Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Stage 0 Chronic Lymphocytic Leukemia Trial in
Completed
- B-cell Chronic Lymphocytic Leukemia
- +4 more
- alemtuzumab
- +9 more
-
Rochester, MinnesotaMayo Clinic
Jun 11, 2020
Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage I Small Lymphocytic Lymphoma Trial in Seattle
Completed
- Chronic Lymphocytic Leukemia
- +8 more
- Fludarabine Phosphate
- +3 more
-
Seattle, Washington
- +1 more
Feb 14, 2020
Contiguous Stage II Small Lymphocytic Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Stage 0 Chronic Lymphocytic
Completed
- Contiguous Stage II Small Lymphocytic Lymphoma
- +5 more
- curcumin
- +3 more
-
Cleveland, OhioCase Comprehensive Cancer Center
Jan 14, 2020
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Terminated
- Accelerated Phase Chronic Myelogenous Leukemia
- +110 more
- rituximab
- +12 more
-
Omaha, NebraskaUniversity of Nebraska Medical Center
Feb 6, 2019
Chronic Lymphocytic Leukemia, Stage 0 Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia Trial in United States
Completed
- Chronic Lymphocytic Leukemia
- +9 more
- Cyclophosphamide
- +3 more
-
Scottsdale, Arizona
- +3 more
Aug 20, 2018
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +117 more
- vorinostat
- +5 more
-
Ann Arbor, MichiganUniversity of Michigan University Hospital
Jun 28, 2018
Lymphoid Leukemia in Remission, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia Trial in Seattle
Completed
- Lymphoid Leukemia in Remission
- +6 more
- Tositumomab and Iodine I 131 Tositumomab
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Oct 10, 2017
Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +178 more
- fludarabine phosphate
- +5 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Apr 17, 2017
B-cell Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia, Stage 0 Chronic Lymphocytic Leukemia Trial in Buffalo (drug,
Terminated
- B-cell Chronic Lymphocytic Leukemia
- +4 more
- lenalidomide
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
May 26, 2016
Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma Trial in Columbus (drug, other,
Terminated
- Chronic Lymphocytic Leukemia
- +11 more
- Alvocidib Hydrochloride
- +4 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Nov 10, 2015
B-cell Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia Trial in
Completed
- B-cell Chronic Lymphocytic Leukemia
- +4 more
- alemtuzumab
- +2 more
-
Chicago, Illinois
- +1 more
May 6, 2014
Refractory Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia Trial in
Terminated
- Refractory Chronic Lymphocytic Leukemia
- +4 more
- sorafenib tosylate
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Apr 17, 2014
Refractory Chronic Lymphocytic Leukemia, Stage II Chronic Lymphocytic Leukemia, Stage III Chronic Lymphocytic Leukemia Trial
Withdrawn
- Refractory Chronic Lymphocytic Leukemia
- +3 more
- laboratory biomarker analysis
- +7 more
- (no location specified)
Jan 10, 2014
B-cell Chronic Lymphocytic Leukemia, Leukemia, Prolymphocytic Leukemia Trial in Boston (drug, biological, other)
Terminated
- B-cell Chronic Lymphocytic Leukemia
- +7 more
- obatoclax mesylate
- +3 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Sep 27, 2013
B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Small Lymphocytic Lymphoma, Noncontiguous Stage II Small Lymphocytic
Terminated
- B-cell Chronic Lymphocytic Leukemia
- +9 more
- alvocidib
- +2 more
-
Columbus, OhioOhio State University Medical Center
Jul 1, 2013
B-cell Chronic Lymphocytic Leukemia, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular
Completed
- B-cell Chronic Lymphocytic Leukemia
- +42 more
- alvocidib
- +3 more
-
Columbus, OhioOhio State University Medical Center
Jun 3, 2013
B-cell Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Stage I Chronic Lymphocytic Leukemia Trial in
Completed
- B-cell Chronic Lymphocytic Leukemia
- +5 more
- alvocidib
- laboratory biomarker analysis
-
Chicago, IllinoisCancer and Leukemia Group B
Jan 16, 2013